Branched-chain amino acids

DIETARY_SUPPLEMENT7 trials

Conditions

Anorexia NervosaHCC - Hepatocellular CarcinomaHealthy Adult MaleHepatic EncephalopathyOvert Hepatic EncephalopathyRunnersnonalcoholic fatty liver diseaseretinitis pigmentosa retinitis pigmentosa

Phase 2

Amino Acids, Serotonin, and Body Weight Regulation

CompletedNCT00343928

Beth Israel Deaconess Medical CenterAnorexia Nervosa

Start: 2006-06-30Updated: 2017-03-23

Clinical trial of TK-98 on retinitis pigmentosa: A prospective, randomized, double-blind, placebo-controlled study

Active, not recruitingJPRN-jRCT2051180072

Ikeda Hanakoretinitis pigmentosa retinitis pigmentosa

Start: 2019-03-19Target: 70Updated: 2026-06-29

Lenvatinib and Pembrolizumab With or Without BCAA in Unresectable HCC

Not yet recruitingNCT07412054

Fudan UniversityHCC - Hepatocellular Carcinoma

Start: 2026-03-01End: 2028-06-01Target: 234Updated: 2026-02-17

Phase 4

Effects of Proteins in Patients With Cirrhosis and Prior Hepatic Encephalopathy

CompletedNCT00955500

Hospital Universitari Vall d'Hebron Research InstituteHepatic Encephalopathy

Start: 2003-01-31End: 2009-01-31Updated: 2009-08-10

Unknown Phase

Effect of branched-chain amino acids supplementation for patients with non alcoholic fatty liver disease

Active, not recruitingJPRN-UMIN000012351

Kagoshima University Hospital, Center for Gastroenterology, Gastroenterological Medicinenonalcoholic fatty liver disease

Start: 2013-11-25Target: 15Updated: 2026-06-29

Human Albumin Infusion in Liver Cirrhosis and Overt Hepatic Encephalopathy (HACHE)

RecruitingNCT06483737

General Hospital of Shenyang Military RegionOvert Hepatic Encephalopathy

Start: 2025-06-24End: 2027-06-30Target: 174Updated: 2025-08-26

Effect of Vitamin D and Branched-chain Amino Acids on Physical Performance and Biomarkers of Muscle Fatigue in Runners

Not yet recruitingNCT07334054

Pedro Julian Flores MorenoHealthy Adult Male, Runners

Start: 2026-01-01End: 2026-06-01Target: 64Updated: 2026-01-12

Related Papers

Human Albumin infusion in liver Cirrhosis and overt Hepatic Encephalopathy (HACHE): protocol of an investigator-initiated, open-label, multicentre, randomised controlled trial.